0001209191-24-002474.txt : 20240131
0001209191-24-002474.hdr.sgml : 20240131
20240131161406
ACCESSION NUMBER: 0001209191-24-002474
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240129
FILED AS OF DATE: 20240131
DATE AS OF CHANGE: 20240131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rahmer Peter
CENTRAL INDEX KEY: 0001959229
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39385
FILM NUMBER: 24583064
MAIL ADDRESS:
STREET 1: C/O RELAY THERAPEUTICS, INC.
STREET 2: 399 BINNEY STREET, 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Relay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001812364
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-370-8837
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-29
0
0001812364
Relay Therapeutics, Inc.
RLAY
0001959229
Rahmer Peter
C/O RELAY THERAPEUTICS, INC.
339 BINNEY STREET, 2ND FLOOR
CAMBRIDGE
MA
02139
0
1
0
0
See remarks
0
Common Stock
2024-01-29
4
S
0
1651
9.64
D
514977
D
Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units ("RSUs") on January 27, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
Includes 471,840 shares underlying RSUs.
Title: Chief Corporate Development Officer
/s/ Thomas Catinazzo, as Attorney-in-Fact
2024-01-31